E. Cupolillo, E. Medina-acosta, H. Noyes, H. Momen, and G. Grimaldi, A revised classification for Leishmania and Endotrypanum, Parasitol Today, vol.16, p.10725899, 2000.

S. Belazzoug, K. Addadi, T. Mokrani, N. Hafirassou, B. Hamrioui et al., Visceral leishmaniasis in Algeria: study of cases hospitalized between, 1975.

, Ann Soc Belg Med Trop, vol.65, pp.329-335, 1985.

M. A. Izri, S. Belazzoug, Y. Boudjebla, J. Dereure, S. Pratlong et al., Leishmania infantum MON-1 isolated from Phlebotomus perniciosus

, Ann Parasitol Hum Comp, vol.65, pp.151-152, 1990.

K. Addadi and J. P. Dedet, Epidemiology of leishmaniasis in Algeria. 6. Survey of clinical cases of infantile visceral leishmaniasis from, 1965.

, Bull Soc Pathol Exot, vol.69, pp.68-75, 1976.

P. Doury, Two autochthonous cases of general leishmaniasis (mediterranean kala-azar) observed at Hoggar

, Arch Institut Pasteur d'Algérie, vol.34, pp.370-379, 1956.

P. Doury, Three new autochthonous cases of general leishmaniasis (Mediterranean kala-azar) observed at Hoggar (Central Sahara)

, Arch Institut Pasteur d'Algérie, vol.35, pp.204-211, 1957.

S. Belazzoug, A. Ammar-khodja, M. Belkaid, and O. Tabet-derraz,

, Bull Soc Pathol Exot, vol.78, pp.615-622, 1985.

Z. Harrat, K. Addadi, M. Belkaid, and O. Tabet-derraz,

, Bull Soc Pathol Exot, vol.85, pp.296-301, 1992.

H. Zait, Y. Ferhani, I. Achir, and B. Hamrioui, É tude de 71 cas de leishmaniose viscérale diagnostiqués au CHU Mustapha d'Alger entre, Médecine Mal Infect, vol.42, pp.119-125, 1998.

A. Adel, A. Boughoufalah, C. Saegerman, R. D. Deken, Z. Bouchene et al., Epidemiology of visceral leishmaniasis in Algeria: An Update, PLoS One, vol.9, pp.28-99207, 2014.

Z. Harrat, S. C. Boubidi, F. Pratlong, R. Benikhlef, B. Selt et al., Description of a dermatropic Leishmania close to L. killicki (Rioux, Lanotte and Pratlong, 1986) in Algeria, Trans R Soc Trop Med Hyg, vol.103, pp.716-720, 2009.

K. Aoun and A. Bouratbine, Cutaneous leishmaniasis in North Africa: a review, Parasite, vol.21, p.14, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01098542

F. Pratlong, J. Dereure, C. Ravel, P. Lami, Y. Balard et al., Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains, Trop Med Int Health, vol.14, pp.1071-1085, 2009.

A. Boudrissa, K. Cherif, I. Kherrachi, S. Benbetka, L. Bouiba et al.,

, Bull Soc Pathol Exot, vol.105, pp.30-35, 2012.

S. Belazzoug, Isolation of Leishmania major Yakimoff & Schokhor, 1914 from Psammomys obesus Gretzschmar, 1828 (Rodentia: Gerbillidae) in Algeria, Trans R Soc Trop Med Hyg, vol.77, p.876, 1983.

S. Belazzoug, Découverte d'un Meriones shawi (Rongeur, gerbillidé) naturellement infesté par Leishmania dans le nouveau foyer de leishmaniose cutanée de Ksar Chellala (Algérie), Bull Soc Pathol Exot, vol.79, pp.630-633, 1986.

M. A. Izri, S. Belazzoug, F. Pratlong, and J. A. Rioux, Isolation of Leishmania major from Phlebotomus papatasi in Biskra. The end of an ecoepidemiological saga

, Ann Parasitol Hum Comp, vol.67, pp.31-32, 1992.

M. A. Izri and S. Belazzoug, Phlebotomus (Larroussius) perfiliewi naturally infected with dermotropic Leishmania infantum at Tenes, Algeria, Trans R Soc Trop Med Hyg, vol.22, p.399, 1993.

R. Benikhlef, Z. Harrat, M. Toudjine, A. Djerbouh, S. Bendali-braham et al.,

, Med Trop, vol.64, pp.381-383, 2004.

A. Izri, A. Bendjaballah, V. Andriantsoanirina, and R. Durand, Cutaneous leishmaniasis caused by Leishmania killicki, Algeria. Emerg Infect Dis, vol.20, pp.502-504, 2014.

S. C. Boubidi, K. Benallal, A. Boudrissa, L. Bouiba, B. Bouchareb et al., Phlebotomus sergenti (Parrot, 1917) identified as Leishmania killicki host in Ghardaïa, south Algeria Microbes Infect, vol.13, pp.691-696, 2011.

J. Moreno and J. Alvar, Canine leishmaniasis: epidemiological risk and the experimental model, Trends Parasitol, vol.18, pp.399-405, 2002.

G. Oliva, A. Scalone, F. Manzillo, V. Gramiccia, M. Pagano et al., Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons, J Clin Microbiol, vol.44, pp.1318-1322, 2006.

K. Aït-oudhia, E. Gazanion, B. Vergnes, B. Oury, and D. Sereno, Leishmania antimony resistance: what we know what we can learn from the field, Parasitol Res, vol.109, p.21800124, 2011.

Z. Harrat, F. Pratlong, S. Belazzoug, J. Dereure, M. Deniau et al., Trans R Soc Trop Med Hyg, vol.90, issue.96, pp.90410-90411, 1996.

S. Belazzoug and R. A. Neal, Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria, Trans R Soc Trop Med Hyg, vol.80, pp.670-671, 1986.

A. Merzougui, M. Berbadj, S. Inouri, and D. Bacha, Prise en charge de la leishmaniose cutanée en Algérie, Med Mal, vol.43, 2013.

L. Gradoni, K. Soteriadou, H. Louzir, A. Dakkak, S. O. Toz et al., Drug regimens for visceral leishmaniasis in Mediterranean countries, Trop Med Int Health, vol.13, p.18764817, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01375214

K. Aït-oudhia, E. Gazanion, D. Sereno, B. Oury, J. P. Dedet et al., In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure, Vet Parasitol, vol.187, pp.386-393, 2012.

A. Maurer-cecchini, S. Decuypere, F. Chappuis, C. Alexandrenne, D. Doncker et al., Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials, Infect Immun, vol.77, pp.2022-2029, 2009.

R. A. Neal and S. Allen, In vitro anti-Leishmanial activity of compounds in current clinical use for unrelated diseases, Drugs Exp Clin Res, vol.14, pp.621-628, 1988.

K. Aït-oudhia, Z. Harrat, R. Benikhlef, J. P. Dedet, and F. Pratlong, Canine Leishmania infantum enzymatic polymorphism: a review including 1023 strains of the Mediterranean area, with special reference to Algeria, Acta Trop, vol.118, pp.80-86, 2011.

Z. Harrat, F. Pratlong, S. Belazzoug, J. Dereure, M. Deniau et al., Leishmania infantum and L. major in Algeria, Trans R Soc Trop Med Hyg, vol.90, pp.625-629, 1996.
URL : https://hal.archives-ouvertes.fr/pasteur-00605364

J. A. Rioux, G. Lanotte, E. Serres, F. Pratlong, P. Bastien et al., Use of isoenzymes. Suggestions for a new classification, Ann Parasitol Hum Comp, vol.65, pp.111-125, 1990.

E. Tai, N. O. , E. Fari, M. , M. I. Miles et al., Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing, Exp Parasitol, vol.97, pp.35-44, 2001.

D. Sereno, E. Guilvard, S. Maquaire, M. Cavaleyra, P. Holzmuller et al., Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas, Acta Trop, vol.80, pp.195-205, 2001.

A. Monte-allegre, B. Vergnes, J. Poncet, F. Mathieu-daude, A. C. Da-silva et al., Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83, Parasitol Res, vol.100, p.17096142, 2007.

R. Brun and . Schönenberger, Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium, Acta Trop, vol.36, pp.289-292, 1979.

A. Gebre-hiwot, G. Tadesse, S. L. Croft, and D. Frommel, An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1, Acta Trop, vol.51, pp.237-245, 1992.

J. Budczies, F. Klauschen, B. V. Sinn, W. D. Schmitt, D. et al., Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization, PLoS One, vol.7, pp.1-7, 2012.

P. Desjeux, The increase in risk factors for leishmaniasis worldwide, Trans R Soc Trop Med Hyg, vol.95, pp.239-243, 2001.

J. C. Dujardin, Risk factors in the spread of leishmaniases: towards integrated monitoring?, Trends Parasitol, vol.22, pp.4-6, 2006.

K. Aoun, F. Jeddi, F. Amri, J. Ghrab, and A. Bouratbine, Current epidemiological data on visceral leishmaniasis in Tunisia, Med Mal infect, vol.39, pp.775-779, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00684000

D. Chaara, N. Haouas, J. P. Dedet, H. Babba, and F. Pratlong, Leishmaniases in Maghreb: an endemic neglected disease, Acta Trop, vol.132, pp.80-93, 2014.

M. Rhajaoui, F. Sebti, H. Fellah, M. Z. Alam, A. Nasereddin et al., Identification of the causative agent of cutaneous leishmaniasis in Chichaoua province, Morocco. Parasite, vol.19, pp.81-84, 2012.

R. Hadighi, M. Mohebali, P. Boucher, H. Hajjaran, A. Khamesipour et al., Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites, PLoS Med, vol.3, 2006.

C. Maia, M. Nunes, M. Marques, S. Henriques, N. Rolão et al., In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs, Exp Parasitol, vol.135, pp.36-41, 2013.

F. Jeddi, C. Mary, K. Aoun, Z. Harrat, R. Benikhlef et al., Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the Western Mediterranean, vol.58, pp.4866-4874, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01060243

B. Pourmohammadi, M. H. Motazedian, F. Handjani, G. Hatam, S. Habibi et al., Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis, Southeast Asian J Trop Med Public Health, vol.42, pp.502-508, 2011.

T. Mohammadzadeh, S. Sadjjadi, P. Habibi, and B. Sarkari, Comparison of agar dilution, broth dilution, cylinder plate and disk diffusion methods for evaluation of anti-leishmanial drugs on Leishmania promastigotes, Iran J Parasitol, vol.7, pp.43-47, 2012.

J. D. Berman and J. Gallalee, Semiautomated assessment of in vitro activity of potential antileishmanial drugs, Antimicrob Agents Chemother, vol.28, pp.723-726, 1985.

R. I. Da-luz, M. Vermeersch, J. Dujardin, P. Cos, and L. Maes, In Vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother, vol.53, pp.5197-5203, 2009.

K. Seifert, P. Escobar, and S. L. Croft, In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent, J Antimicrob Chemother, vol.65, pp.508-511, 2010.

G. De-muylder, K. Ang, S. Chen, M. R. Arkin, J. C. Engel et al., A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit, PLoS Negl Trop Dis, vol.5, 2011.

P. Holzmuller, M. Hide, D. Sereno, and J. L. Lemesre, Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: impact on in vitro parasite developmental cycle and metabolic enzyme activities, Infect Genet Evol, vol.6, pp.187-197, 2006.

D. Sereno, C. Da-silva, A. Mathieu-daude, F. Ouaissi, and A. , Advances and perspectives in Leishmania cell based drug-screening procedures, Parasitol Int, vol.56, pp.3-7, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00376733

E. De-la-llave, H. Lecoeur, A. Besse, G. Milon, E. Prina et al., A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations, Cell Microbiol, vol.13, p.20846338, 2011.

E. Prina and T. Lang, Imaging Leishmania development in their host cells, Trends Parasitol, vol.25, pp.464-473, 2009.

L. Lachaud, N. Bourgeois, M. Plourd, P. Leprohon, P. Bastien et al., Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum, Clin Infect Dis, vol.48, pp.16-22, 2009.

M. Antoniou, C. Doulgerakis, F. Pratlong, J. Dedet, and Y. Tselentis, Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum, Am J Trop Med Hyg, vol.71, pp.71-72, 2004.

N. Gupta, N. Goyal, and A. K. Rastogi, In vitro cultivation and characterization of axenic amastigotes of Leishmania, Trends Parasitol, vol.17, pp.150-153, 2001.

D. Sereno and J. L. Lemesre, Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents, Antimicrob Agents Chemother, vol.41, pp.972-976, 1997.

D. Sereno, P. Holzmuller, and J. L. Lemesre, Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum, Acta Trop, vol.74, pp.25-31, 2000.

V. Yardley, N. Ortuno, A. Llanos-cuentas, F. Chappuis, S. De-doncker et al., American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility?, J Infect Dis, vol.194, pp.1168-1175, 2006.

S. Sundar, Treatment of visceral leishmaniasis, Med Microbiol Immunol, vol.190, pp.89-103, 2001.

M. Vermeersch, R. I. Da-luz, K. Toté, J. Timmermans, P. Cos et al., In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences, Antimicrob Agents Chemother, vol.53, pp.3855-3859, 2009.

B. Vergnes, B. Gourbal, I. Girard, S. Sundar, J. Drummelsmith et al., A Proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death, Mol Cell Prot, pp.88-101, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00170702

H. Denton, M. Gregor, J. C. Coombs, and G. H. , Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1, Biochem J, vol.381, pp.405-412, 2004.

Y. Zhou, N. Messier, M. Ouellette, B. P. Rosen, and R. Mukhopadhyay, Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam, J Biol Chem, vol.279, pp.37445-37451, 2004.

, Antimicrobial resistance: global report on surveillance, WHO, 2014.

D. Sereno, C. Maia, and K. Aït-oudhia, Antimony resistance and environment: elusive links to explore during Leishmania life cycle, Int J Parasitol: Drugs & Drugs Resistance, vol.2, pp.200-203, 2012.